MYRIAD GENETICS, INC. Acquisitions, Net of Cash Acquired
MYRIAD GENETICS, INC. (MYGN) reported Acquisitions, Net of Cash Acquired of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2025-02-28
- MYRIAD GENETICS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2019-06-30 was $0.00.
- MYRIAD GENETICS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2019-03-31 was $0.00.
- MYRIAD GENETICS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2018-12-31 was -$1.10M.
- MYRIAD GENETICS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2018-09-30 was $279.60M.
- MYRIAD GENETICS, INC. payments to acquire businesses, net of cash acquired for fiscal 2024 was $0.00.
- MYRIAD GENETICS, INC. payments to acquire businesses, net of cash acquired for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- MYRIAD GENETICS, INC. payments to acquire businesses, net of cash acquired for fiscal 2022 was $57.20M.
- MYRIAD GENETICS, INC. payments to acquire businesses, net of cash acquired for fiscal 2021 was $0.00.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 12 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-28 | |||||
| 2023-12-31 | $0.00 10-K · filed 2025-02-28 | |||||
| 2022-12-31 | $57.20M 10-K · filed 2025-02-28 | |||||
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 | |||||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 | |||||
| 2020-06-30 | $0.00 10-K · filed 2023-03-01 | |||||
| 2019-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $0.00 derived: sum of 2 quarters · filed 2022-02-25 | -$1.10M derived: sum of 3 quarters · filed 2022-02-25 | $278.50M 10-K · filed 2022-02-25 | ||
| 2019-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-06 | -$1.10M derived: sum of 2 quarters · filed 2020-05-06 | $278.50M 10-Q · filed 2020-05-06 | |||
| 2018-12-31 | -$1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-07 | $278.50M 10-Q · filed 2020-02-07 | ||||
| 2018-09-30 | $279.60M 10-Q · filed 2019-11-06 | |||||
| 2018-06-30 | $0.00 10-KT · filed 2021-03-16 | |||||
| 2017-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-13 | $0.00 derived: sum of 2 quarters · filed 2019-08-13 | $3.10M derived: sum of 3 quarters · filed 2019-08-13 | $216.10M 10-K · filed 2019-08-13 | ||
| 2017-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | $3.10M derived: sum of 2 quarters · filed 2018-05-09 | $216.10M 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-07 | $216.10M 10-Q · filed 2018-02-07 | ||||
| 2016-09-30 | $213.00M 10-Q · filed 2017-11-08 | |||||
| 2016-06-30 | $37.00M 10-K · filed 2018-08-24 | |||||
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-09 | $20.10M 10-K · filed 2017-08-09 | ||||
| 2015-03-31 | $20.10M 10-Q · filed 2016-05-04 | $20.11M 10-Q · filed 2015-05-06 | ||||
| 2014-06-30 | -$31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-10 | $223.50M 10-K · filed 2016-08-10 | $223.53M 10-K · filed 2014-08-13 | |||
| 2014-03-31 | $223.53M 10-Q · filed 2015-05-06 | |||||
| 2012-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-14 | $0.00 derived: sum of 2 quarters · filed 2013-08-14 | $0.00 derived: sum of 3 quarters · filed 2013-08-14 | $799.00K 10-K · filed 2013-08-14 | ||
| 2012-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-08 | $0.00 derived: sum of 2 quarters · filed 2013-05-08 | $799.00K 10-Q · filed 2013-05-08 | |||
| 2011-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-06 | $799.00K 10-Q · filed 2013-02-06 | ||||
| 2011-09-30 | $799.00K 10-Q · filed 2012-11-09 | |||||
| 2011-06-30 | $79.42M 10-K · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |